Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients

Europace

Volumn 18, Issue 7, 2016, Pages 1000-1005

  Podd, Steven J ^a   Sugihara, Conn ^a   Furniss, Stephen S ^a   Sulke, Neil ^a  

^a EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation; Atrial fibrillation ablation; Atrial fibrillation burden; Implantable cardiac monitoring; Loop recorders

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE COMPARISON; FEMALE; FOLLOW UP; GOLD STANDARD; HEART ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIAC MONITOR; MALE; MIDDLE AGED; PAROXYSMAL ATRIAL FIBRILLATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; ADVERSE EFFECTS; AMBULATORY ELECTROCARDIOGRAPHY; CATHETER ABLATION; COMPARATIVE STUDY; PROCEDURES; PROSTHESES AND ORTHOSES; PULMONARY VEIN; UNITED KINGDOM;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; PULMONARY VEINS; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

EID: 84983593703     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv367     Document Type: Article

References (24)

1. Stewart S, Hart CL, Hole DJ, McMurray JJV. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-21.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5.
3. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-8.
4. Rho RW, Page RL. Asymptomatic atrial fibrillation. Prog Cardiovasc Dis 2005;48: 79-87.
5. Page R, Wilkinson W, Clair W, McCarthy E, Pritchett E. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-7.
6. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23.
7. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657-63.
8. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003;107:1614-9.
9. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-20.
10. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009;20:241-8.
11. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
12. Brignole M, Vardas P, Hoffman E, Huikuri H, Moya A, Ricci R et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace 2009;11: 671-87.
13. Catheter Ablation versus Antiarrythmic Drug Therapy for Atrial Fibrillation Trial, CABANA Trial. [Internet]. clinicaltrials.gov. http://www.clinicaltrials.gov/ct2/show/NCT00 911508.
14. Aliot E, Brandes A, Eckardt L, Elvan A, Gulizia M, Heidbuchel H et al. The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial. Eur Heart J 2015;36:255-6.
15. Sanna T, Diener H-C, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370: 2478-86.
16. Tieleman RG, Plantinga Y, Rinkes D, Bartels GL, Posma JL, Cator R et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace 2014;16:1291-5.
17. Beukema R, Beukema WP, Sie HT, Misier AR, Delnoy PP, Elvan A. Monitoring of atrial fibrillation burden after surgical ablation: relevancy of end point criteria after radiofrequency ablation treatment of patients with lone atrial fibrillation. Interact Cardiovasc Thorac Surg 2009;9:956-9.
18. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck K-H, Lebedev D et al. Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial. Circ Arrhythm Electrophysiol 2010;3:141-7.
19. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009;2: 474-80.
20. Camm AJ, Corbucci G, Padeletti L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol 2012;110:270-6.
21. Arya A, Piorkowski C, Sommer P, Kottkamp H, Hindricks G. Clinical implications of various follow up strategies after catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol 2007;30:458-62.
22. Kaufman ES, Israel CW, Nair GM, Armaganijan L, Divakaramenon S, Mairesse GH et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm 2012;9: 1241-6.
23. Sugihara C, Veasey R, Freemantle N, Podd S, Furniss S, Sulke N. The development of AF over time in patients with permanent pacemakers: objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF. Europace 2015;17: 864-70.
24. Jung W, Zvereva V, Rillig A, Roggenbuck B, Sadeghzadeh G, Kohler J. How to use implantable loop recorders in clinical trials and hybrid therapy. I Interv Card Electrophysiol 2011;32:227-32.